Robeco Institutional Asset Management B.V. Has $134.71 Million Stake in Cardinal Health, Inc. $CAH

Key Points

• Robeco Institutional Asset Management B.V. reduced its stake in Cardinal Health, Inc. by 3.7%, owning 801,814 shares valued at approximately $134.71 million after selling 30,421 shares during the second quarter.
• Cardinal Health recently announced a quarterly dividend of $0.5107 per share, with an ex-dividend date set for October 1st, yielding an annualized payout of 1.3% and a payout ratio of 31.63%.
• Despite a small revenue increase, Cardinal Health's quarterly earnings exceeded analysts' expectations, reporting $2.08 EPS, up from $1.84 EPS from the same quarter last year.

Robeco Institutional Asset Management B.V. decreased its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 801,814 shares of the company's stock after selling 30,421 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.34% of Cardinal Health worth $134,705,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Principal Financial Group Inc. raised its stake in Cardinal Health by 5.3% in the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock worth $43,510,000 after purchasing an additional 15,956 shares in the last quarter. Kingswood Wealth Advisors LLC raised its stake in Cardinal Health by 17.2% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock worth $429,000 after purchasing an additional 457 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in Cardinal Health by 25.8% in the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock valued at $1,811,000 after buying an additional 2,694 shares during the period. Golden State Wealth Management LLC increased its holdings in Cardinal Health by 569.5% in the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock valued at $54,000 after buying an additional 336 shares during the period. Finally, North Capital Inc. bought a new position in Cardinal Health in the 1st quarter valued at about $83,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Up 0.5%

CAH opened at $157.79 on Thursday. The company's 50 day moving average is $152.11 and its 200-day moving average is $149.90. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The company has a market cap of $37.49 billion, a P/E ratio of 24.46, a PEG ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the company posted $1.84 EPS. The firm's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.

Insider Buying and Selling at Cardinal Health

In related news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 over the last quarter. Insiders own 0.12% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Wells Fargo & Company reissued an "overweight" rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Evercore ISI decreased their target price on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a report on Wednesday, August 13th. Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Robert W. Baird raised their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a report on Wednesday, August 13th. Finally, Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a report on Tuesday, August 12th. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.